Anjana, It appears Dr. Shah presented this at ASCO of 2005 (June). He very well may not have the latest information on which programs have been stopped.
Do you know whether the MDACC trial for SKI-606 is explicitly recruiting patients with the T315I mutation - so they can determine whether or not it works? I didn't realize there was a SKI-606 publication addressing T315I. Thanks! Shane --~--~---------~--~----~------------~-------~--~----~ [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [EMAIL PROTECTED] For more options, visit this group at http://groups.google.com/group/CMLHope -~----------~----~----~----~------~----~------~--~---
